US Patent 10689437 RSV-specific antibodies and functional parts thereof
Patent 10689437 was granted and assigned to MedImmune on June, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 8, 2018
Date of Patent
June 23, 2020
Patent Applicant
Patent Application Number
16003455
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10689437 RSV-specific antibodies and functional parts thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.